Elands J - Search Results

1

The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions.

Mouillac B, Chini B, Balestre MN, Elands J, Trumpp-Kallmeyer S, Hoflack J, Hibert M, Jard S, Barberis C. Mouillac B, et al. Among authors: elands j. J Biol Chem. 1995 Oct 27;270(43):25771-7. doi: 10.1074/jbc.270.43.25771. J Biol Chem. 1995. PMID: 7592759 Free article.

2

Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.

Chini B, Mouillac B, Ala Y, Balestre MN, Trumpp-Kallmeyer S, Hoflack J, Elands J, Hibert M, Manning M, Jard S, et al. Chini B, et al. Among authors: elands j. EMBO J. 1995 May 15;14(10):2176-82. doi: 10.1002/j.1460-2075.1995.tb07211.x. EMBO J. 1995. PMID: 7774575 Free PMC article.

3

Identification of agonist binding sites of vasopressin and oxytocin receptors.

Mouillac B, Chini B, Balestre MN, Jard S, Barberis C, Manning M, Tribollet E, Trumpp-Kallmeyer S, Hoflack J, Elands J, et al. Mouillac B, et al. Among authors: elands j. Adv Exp Med Biol. 1995;395:301-10. Adv Exp Med Biol. 1995. PMID: 8713980

4

Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.

Chini B, Mouillac B, Ala Y, Balestre MN, Cotte N, Trumpp-Kallmeyer S, Hoflack J, Elands J, Hibert M, Manning M, et al. Chini B, et al. Among authors: elands j. Adv Exp Med Biol. 1995;395:321-8. Adv Exp Med Biol. 1995. PMID: 8713982

5

Identification of a single residue responsible for agonist selectivity in the oxytocin-vasopressin receptors.

Chini B, Mouillac B, Ala Y, Balestre MN, Trumpp-Kallmeyer S, Hoflack J, Elands J, Hibert M, Manning M, Jard S, Barberis C. Chini B, et al. Among authors: elands j. Ann N Y Acad Sci. 1997 May 30;812:218-21. doi: 10.1111/j.1749-6632.1997.tb48181.x. Ann N Y Acad Sci. 1997. PMID: 9186749 No abstract available.

6

Pharmacology of oxytocin and vasopressin receptors in the central and peripheral nervous system.

Barberis C, Audigier S, Durroux T, Elands J, Schmidt A, Jard S. Barberis C, et al. Among authors: elands j. Ann N Y Acad Sci. 1992 Jun 12;652:39-45. doi: 10.1111/j.1749-6632.1992.tb34344.x. Ann N Y Acad Sci. 1992. PMID: 1320833 Review. No abstract available.

7

Novel approach to the design of synthetic radioiodinated linear V1A receptor antagonists of vasopressin.

Manning M, Bankowski K, Barberis C, Jard S, Elands J, Chan WY. Manning M, et al. Among authors: elands j. Int J Pept Protein Res. 1992 Sep-Oct;40(3-4):261-7. doi: 10.1111/j.1399-3011.1992.tb00300.x. Int J Pept Protein Res. 1992. PMID: 1478783

8

[3H]-[Thr4,Gly7]OT: a highly selective ligand for central and peripheral OT receptors.

Elands J, Barberis C, Jard S. Elands J, et al. Am J Physiol. 1988 Jan;254(1 Pt 1):E31-8. doi: 10.1152/ajpendo.1988.254.1.E31. Am J Physiol. 1988. PMID: 2827511

9

125I-d(CH2)5[Tyr(Me)2, Tyr(NH2)9]AVP: iodination and binding characteristics of a vasopressin receptor ligand.

Elands J, Barberis C, Jard S, Lammek B, Manning M, Sawyer WH, de Kloet ER. Elands J, et al. FEBS Lett. 1988 Mar 14;229(2):251-5. doi: 10.1016/0014-5793(88)81135-9. FEBS Lett. 1988. PMID: 2964381 Free article.

10

125I-labelled d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH2(9)]OVT: a selective oxytocin receptor ligand.

Elands J, Barberis C, Jard S, Tribollet E, Dreifuss JJ, Bankowski K, Manning M, Sawyer WH. Elands J, et al. Eur J Pharmacol. 1988 Mar 1;147(2):197-207. doi: 10.1016/0014-2999(88)90778-9. Eur J Pharmacol. 1988. PMID: 2835249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters